Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - Emmaus Life Sciences, Inc. | s107105_10q.htm |
| EX-31.2 - EXHIBIT 31.2 - Emmaus Life Sciences, Inc. | s107105_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Emmaus Life Sciences, Inc. | s107105_ex31-1.htm |
| EX-10.30 - EXHIBIT 10.30 - Emmaus Life Sciences, Inc. | s107105_ex10-30.htm |
| EX-4.9 - EXHIBIT 4.9 - Emmaus Life Sciences, Inc. | s107105_ex4-9.htm |
| EX-3.1 - EXHIBIT 3.1 - Emmaus Life Sciences, Inc. | s107105_ex3-1.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in connection with the filing of the Quarterly Report on Form 10-Q for the quarter ended June 30, 2017 (the “Report”) by MYnd Analytics, Inc.. (the “Registrant”), the undersigned hereby certifies that to the best of his knowledge:
1. the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
| Date: August 14, 2017 | /s/ George C. Carpenter IV |
| George C. Carpenter IV | |
| Chief Executive Officer (Principal Executive Officer) | |
| Date: August 14, 2017 | /s/ Donald D’Ambrosio |
| Donald D’Ambrosio | |
| Chief Financial Officer (Principal Financial Officer) |